ArticleiScience2026
A systematic transcriptomic atlas and predictive framework for metabolite-driven T cell state transitions.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gut microbial and endogenous metabolites are key regulators at the interface of host metabolism and immunity, yet their global effects on human T cell states remain poorly defined. Here, we profile primary human T cell responses to 364 endogenous and microbiota-derived metabolites using high-throughput digital RNA with perturbation of genes sequencing (DRUG-seq), revealing structured transcriptional trajectories spanning baseline, metabolically primed, and highly activated states. We develop DRUG-seq-PerturbFormer, a multi-task deep learning framework that quantitatively captures perturbation magnitude and directionality across these states. This analysis identifies a subset of metabolites that robustly reprogram T cell transcriptional programs. In a dextran sulfate sodium (DSS)-induced colitis model, representative candidates attenuated disease severity and were associated with suppression of inflammatory programs and partial restoration of immune homeostasis. Collectively, these findings show that metabolites act as signals shaping T cell function via transcription, nominating immunomodulatory targets for inflammatory diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.